Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX) and Topiramate (TOPAMAX) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
Headache: The Journal of Head and Face Pain, 11/05/09
Mathew NT et al. – OnabotulinumtoxinA and topiramate demonstrated similar efficacy in the prophylactic treatment of chronic migraine (CM). Patients receiving onabotulinumtoxinA had fewer AEs and discontinuations.
Related Articles
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 94%
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
Relevance Score: 89%
Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association
Women's Health, 10/30/09
Relevance Score: 81%
Urinary 6-Sulphatoxymelatonin Levels Are Depressed in Chronic Migraine and Several Comorbidities
Headache: The Journal of Head and Face Pain, 10/12/09
Relevance Score: 81%
Clinical management of motility disorders in children
Seminars in Pediatric Surgery, 10/01/09
Relevance Score: 81%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-platelet Agents
Discovery Medicine, 12/15/09
Glycomimetic Drugs - A New Source of Therapeutic Opportunities
Discovery Medicine, 12/15/09
Molecular mechanisms of toxicity of simvastatin, widely used cholesterol-lowering drug. A review
Central European Journal of Medicine, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


